Variability of skin autofluorescence measurement over 6 and 12 weeks and the influence of benfotiamine treatment. [electronic resource]
Producer: 20140317Description: 733-7 p. digitalISSN:- 1557-8593
- Adult
- Aged
- Chelating Agents -- therapeutic use
- Cross-Over Studies
- Diabetes Complications -- diagnosis
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Female
- Fluorescence
- Glycation End Products, Advanced -- metabolism
- Humans
- Hyperglycemia -- blood
- Male
- Middle Aged
- Postprandial Period -- physiology
- Reproducibility of Results
- Skin -- drug effects
- Thiamine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.